Contributions of Bcl-xL to acute and long term changes in bioenergetics during neuronal plasticity.
Mitochondria manufacture and release metabolites and manage calcium during neuronal activity and synaptic transmission, but whether long term alterations in mitochondrial function contribute to the neuronal plasticity underlying changes in organism behavior patterns is still poorly understood. Although normal neuronal plasticity may determine learning, in contrast a persistent decline in synaptic strength or neuronal excitability may portend neurite retraction and eventual somatic death. Anti-death proteins such as Bcl-xL not only provide neuroprotection at the neuronal soma during cell death stimuli, but also appear to enhance neurotransmitter release and synaptic growth and development. It is proposed that Bcl-xL performs these functions through its ability to regulate mitochondrial release of bioenergetic metabolites and calcium, and through its ability to rapidly alter mitochondrial positioning and morphology. Bcl-xL also interacts with proteins that directly alter synaptic vesicle recycling. Bcl-xL translocates acutely to sub-cellular membranes during neuronal activity to achieve changes in synaptic efficacy. After stressful stimuli, pro-apoptotic cleaved delta N Bcl-xL (ΔN Bcl-xL) induces mitochondrial ion channel activity leading to synaptic depression and this is regulated by caspase activation. During physiological states of decreased synaptic stimulation, loss of mitochondrial Bcl-xL and low level caspase activation occur prior to the onset of long term decline in synaptic efficacy. The degree to which Bcl-xL changes mitochondrial membrane permeability may control the direction of change in synaptic strength. The small molecule Bcl-xL inhibitor ABT-737 has been useful in defining the role of Bcl-xL in synaptic processes. Bcl-xL is crucial to the normal health of neurons and synapses and its malfunction may contribute to neurodegenerative disease.
Dept. of Internal Medicine, P.O. Box 208001, Yale University School of Medicine, New Haven, CT 06520, USA; Dept. of Neurobiology, P.O. Box 208020, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: Elizabeth.jonas@yale.edu.
Elizabeth A
EA
Jonas
D000818:Animals; D004734:Energy Metabolism; D006801:Humans; D007473:Ion Channels / Q000378:metabolism; D063154:Mitochondrial Dynamics; D051336:Mitochondrial Membranes / Q000378:metabolism; D009473:Neuronal Plasticity; D051020:bcl-X Protein / Q000378:metabolism*
D007473:Ion Channels; D051020:bcl-X Protein
ATP synthase; Bcl-xL; Mitochondria; Neurodegenerative disease; Synapse; Synaptic plasticity